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Introduction: Human infection with avian influenza A (H7N9) virus was first reported on March, 2013 in the Yangtze
River Delta region of China. The majority of human cases were detected in mainland China; other regions out of
mainland China reported imported human cases, including Hong Kong SAR, Taiwan (the Republic of China) and Malaysia,
due to human transportation. Here, we report the first human case of H7N9 infection imported into Guizhou Province
during the Spring Festival travel season in January 2014.
Case presentation: In early January 2014, a 38-year-old healthy Chinese man, a migrant worker returning from previously
H7N9-affected Zhejiang Province, was identified as the first human case of infection with avian influenza A(H7N9) virus in
Guizhou Province. He developed fever in Zhejiang at the beginning of January 2014, and returned to Guizhou for the
Chinese New Year the next day. He went to seek medical care, but deteriorated rapidly and died on day 8 after his illness
onset. The influenza virus A/Guizhou/01502/2014 isolated from the patient had 99% identity with viruses circulating in the
Yangtze River Delta region. Selected amino acids substitutions, well-known to be associated with mammalian adaptation,
viral replication and drug resistance were similar to other H7N9 viruses circulating in humans.
Conclusions: Epidemiology investigation and laboratory results confirmed it was the first imported case of H7N9
infection in Guizhou Province. This finding further indicated that more human H7N9 cases may be detected in other
regions due to frequent travel both domestically and internationally.
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The first wave of human infections with avian influenza
A(H7N9) virus began in spring and subsided by summer
2013 in China [1], and it has re-emerged since October
2013 [2]. As of March 10, 2014, a total of 379 cases and
135 deaths were reported in mainland China [3]. How-
ever, human cases were also detected in Hong Kong
SAR, Taiwan (the Republic of China) [4] and recently
the Malaysian Ministry of Health announced the first
imported case outside of China on February 12, 2014
[5]. It indicated that human cases could be exported to* Correspondence: yshu@cnic.org.cn
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unless otherwise stated.other regions by frequent travel both domestically and
internationally. Each year, billions of people migrate for
the Spring Festival in China, therefore increasing the risk
of infectious diseases spreading. Here we report the first
human case of H7N9 infection imported to Guizhou
Province from the epidemic region during the period of
the so-called largest annual human migration.Case presentation
The patient was a 38-year-old healthy Chinese man, a
migrant worker who worked in Zhejiang Province. As
shown in Figure 1, he developed influenza-like illness
(ILI) symptoms, including headache and 40°C fever at
the beginning of January 2014, and sought medical at-
tention in a village clinic and received infusion therapy.
He went back to his hometown in Guizhou Province forThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 Timeline of potential exposure and medical consultation of a laboratory-confirmed imported influenza A(H7N9) case, Guizhou Province,
China, January 2014.
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from Zhejiang Province one day after he developed
fever. He then sought medical care in a village clinic and
a township hospital when he arrived at his hometown.
His chest radiograph showed pneumonia in the lower
lobe of his left lung (the CT value ranged from −12 to
approximately −19) and he was hospitalized in a town-
ship hospital on day 5 after his illness onset. He experi-
enced high fever and rapid progression, and was
transferred to a provincial general hospital in Zunyi city.
He was diagnosed as severe pneumonia, deteriorated
rapidly and died on day 8 after his illness onset. He had
received symptomatic treatment during the clinical
treatment and all drugs that had been used in the town-
ship hospital and the general hospital in Zunyi city are
listed in Table 1. No antiviral drugs were administrated
during the clinical treatment. The case was reported
through the Chinese surveillance system for pneumonia
with unknown etiology and confirmed as human infec-
tion with avian influenza A(H7N9) virus by means of
RT-PCR, virus isolation and full genome sequencing at
the Chinese National Influenza Center (CNIC). Since
the patient had died, written informed consent was
obtained from the patient’s next-of-kin for publication of
this case report.Table 1 Drugs used during clinical treatment in hospital
Days after illness onset Treatment
Day 5 Antibiotic treatment with vancomycin+
ceftazidime+aminoglycoside
Use of omeprazole to prevent stress ulcer
Use of dexamethasone to reduce
inflammatory exudation
Day 7 Meropenem
Compound aminopyrine and acetaminophen
Ceftriaxone, bromhexine, doxofylline and
coenzyme complexSixty-one close contacts were identified by epidemio-
logical survey, including 36 health-care personnel, eight
medical escorts and 17 households and family contacts.
As a public health response, written informed consents
from contacts can be waived according to Chinese law.
The close contacts were medically monitored for seven
consecutive days; no ILI symptoms were observed in all
contacts except for the patient’s family members. One
family member appeared with a sore throat and devel-
oped a 38°C fever five to seven days after the patient’s
illness onset, and another developed a sore throat with-
out fever seven days after the patient’s illness onset.
Continuous throat swabs were collected from them; all
the samples were negative for H7N9 influenza virus.
Antibody response to H7N9 virus was not detected from
the paired sera of all contacts.
The influenza virus A/Guizhou/01502/2014 was iso-
lated from the patient. The PB2 gene had a high degree
of similarity (99%) to viruses isolated from human in
Zhejiang Province. Another seven segments showed the
highest identity with viruses isolated from birds in the
Yangtze River Delta region, where Zhejiang Province is
located (Table 2). The phylogenetic analysis further dem-
onstrated all eight gene segments were clustered withTable 2 The highest homology of the virus isolated from
the patient with other H7N9 viruses
Segment Strain Identity
PB2 A/Zhejiang/LS01/2014 (H7N9) 2272/2280 (99%)
PB1 A/chicken/Suzhou/040201H/2013 (H7N9) 2265/2274 (99%)
PA A/duck/Sunan/040802G/2013 (H7N9) 2145/2151 (99%)
HA A/chicken/Suzhou/097-1/2013 (H7N9) 1668/1683 (99%)
NP A/tree_sparrow/Shanghai/01/2013 (H7N9) 1493/1497 (99%)
NA A/chicken/Suzhou/040201H/2013 (H7N9) 1389/1398 (99%)
MP A/chicken/Suzhou/097-1/2013 (H7N9) 981/982 (99%)
NS A/pigeon/Wuxi/0405007G/2013 (H7N9) 836/838 (99%)
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A/Shanghai/1/2013 (SH1, the first H7N9 virus isolate),
A/Anhui/1/2013 (AH1, the vaccine strain recommended
by the World Health Organization) and those six virus
isolates with highest identity with A/Guizhou/01502/
2014 mentioned in Table 2 were selected for characteris-
tic comparison of the critical amino acids residues
(Table 3). Similar to those viruses, the mammalian-
adaptive mutations such as G186V and Q226L in the
HA gene that were previously reported [6] were found




















































Figure 2 Phylogenetic tree of HA and NA gene segments of the Guizhou
analyzed for the two surface genes, HA (A) and NA (B). The Guizhou isolate
with a black triangle. The bootstrap values ≥0.6 are shown at the major noNA gene and suggested the effectiveness of oseltamivir
antiviral treatment. The virus possessed a 627K mutation
in the PB2 gene, which was proposed to be associated
with high polymerase activity and increased the viru-
lence in mice [7]. The PB1 L368V mutation was found
in this virus, which increased transmission in ferret [8].
The signature amino acids of the human influenza virus
in the PA gene were detected, including V100A, K356R
and S409N [9,10]; however, a unique mutation L336M
in the PA gene that had only been reported in a Hong




















































isolate. The H7N9 viruses that were most like the Guizhou isolate were
was marked with a black square and the most likely virus was marked
























































































































































































































































































































































Figure 3 Phylogenetic tree of six internal gene segments of the Guizhou isolate. The H7N9 viruses that were most like the Guizhou isolate were
analyzed for six internal genes, PB2 (A), PB1 (B), PA (C), NP (D), MP (E), NS (F). The Guizhou isolate was marked with a black square and the most
likely virus was marked with a black triangle. The bootstrap values ≥0.6 are shown at the major nodes of the phylogenetic trees.
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This is the first imported human H7N9 case of a mi-
grant worker moving from epidemic areas to unaffected
regions during the Spring Festival migration, which is aperiod of travel in China with an extremely high traffic
load around the time of the Chinese New Year.
Unlike most previously reported fatal cases of patients
who were older and/or who had underlying medical
Table 3 Comparison of selected molecular markers between A/Guizhou/01502/2014 and representative H7N9 viruses
Protein Phenotypic consequencesa Amino acid
position/motifb
GZ 01502 SH1 AH1 ZJLS01 SZ040201H SN040802G CK/SZ097-1 tree_sparrow/SH1 pigeon/WX/0405007G
HA Increased virus binding to human-type
receptors (α2-6)
G186V V G V V V V V V V
Q226L L Q L L L Q L L Q
NA Enhanced virulence in mice/adaption and
transmission in domestic poultry
69-73 amino
acids deletion
Yes Yes Yes Yes Yes Yes Yes Yes Yes
Related to drug resistance R292K R K R K R R R R R
PB2 Increased virulence in mice E627K K K K K E E E K E
Enhanced virulence and transmission in
guinea pigs
D701N D D D D D D D D D
PB1 Increased transmission in ferret I368V V I V V V V V V V
Increased replication in mammalian cells L598P L M L L L L L L L
PB1-F2 Increased pathogenicity in mice 87-90 amino
acids in length
90 90 90 90 90 90 25 90 90
PA Increased polymerase activity L336M L L L L L L L L L
Species-associated signature positions V100A A A A A A A A A A
K356R R R R R R R R R R
S409N N N N N N N N N N
aThe mutation to the right of the amino acid position confers the phenotype described below.
bThe HA gene was under the H3 numbering system. The NA gene was under the N2 numbering system. Other internal genes were numbered from the start codon (Met).
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without any underlying medical conditions. No muta-
tions associated with antiviral resistance were detected;
one possibility for the rapid deterioration and death of
the patient may be due to the fact antiviral drugs were
not used during his treatment. The virus isolated from
the patient showed a high identity with viruses circulat-
ing in the Yangtze River Delta region and he developed
respiratory syndromes before his arrival in Guizhou
Province. He visited a neighborhood live poultry market
before his illness onset, which indicated the potential
infection source was likely to be the infected poultry in
the market, as previously reported elsewhere [12-14].
Further, the H7N9 virus was not detected in Guizhou
based on the results of poultry-related environmental
surveillance since 2009 (data not shown). These data
concluded that the case had been introduced from an
affected region by the movement of people. Imported
human cases of the H7N9 virus travelling from affected
areas to non-endemic areas domestically and inter-
nationally have been reported in Hong Kong SAR,
Taiwan (the Republic of China) and Malaysia during the
first and second wave of H7N9 infections [4,5,15]. In
each year, millions of migrant workers from rural areas
of Guizhou Province go to work in the Yangtze River
Delta and the Pearl River Delta and return home for a
reunion with their family. With the increasingly frequent
movement of people, it is foreseen that more human
H7N9 cases may be detected in other regions due to
frequent travel both domestically and internationally.
Considering the rapidly progressive pneumonia, acute
respiratory distress syndrome (ARDS), the high rates of
ICU admission and death, early detection and antiviral
drug therapy of suspected cases imported from affected
areas are essential to reduce the case fatality rate of
H7N9 virus infection.
The undetected H7N9 virus of the respiratory speci-
mens and the negative antibody response to H7N9 in his
family members who presented clinical syndromes indi-
cated that the transmission from the patient to his fam-
ily members could be ruled out.
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